November 3, 2022 – announcement no. 10
Chr. Hansen Holding A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in Chr. Hansen Holding A/S made by persons discharging managerial responsibilities in Chr. Hansen Holding A/S and/or persons closely related with them.
Please see attachment.
For further information please contact:
Anders Mohr Christensen, Vice President Group Strategy & Investor Relations, Tel: +45 2515 2364
Cristina Rønde Hefting, Senior Investor Relations Manager, Tel: +45 4072 1224
Kathrine Westermann, Head of Media Relations, Tel: +45 2381 5595
Attachment
By Cecile Brosset, CEO of Sonio The landscape of ultrasound technology is rapidly evolving, driven…
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT)…
Leveraging the Power of Data to Accelerate Scientific Discovery and Improve Health in the Bronx…
SINGAPORE and SOUTH SAN FRANCISCO, Calif., May 6, 2025 /PRNewswire/ -- Plasmidsaurus, the company that…
OMAHA, Neb., May 6, 2025 /PRNewswire/ -- Medical Solutions, one of the nation's largest and most…
KardiaMobile 6L Max is powered by advanced AI to offer a wider range of arrhythmia…